Mrs Jasmyn Sharee Winston, | |
343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122-4015 | |
(314) 206-3400 | |
Not Available |
Full Name | Mrs Jasmyn Sharee Winston |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 343 S Kirkwood Rd, Kirkwood, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487918827 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jasmyn Sharee Winston, 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122-4015 Ph: (314) 206-3400 | Mrs Jasmyn Sharee Winston, 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122-4015 Ph: (314) 206-3400 |
News Archive
Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims.
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it is the first CRO on the West Coast to acquire the Xcelodose system, enhancing the company's preclinical and early phase clinical GMP supply capabilities.
Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 6 days ago
Alyssa Brussee Patel, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 112 W Jefferson Ave Ste 130, Kirkwood, MO 63122 Phone: 314-223-5456 | |
Mark Beidle, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 215 S Kirkwood Rd, Suite 202, Kirkwood, MO 63122 Phone: 314-822-0650 | |
Mrs. Cathy Ann Williams, MSW,LCSW,CEAP Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122 Phone: 314-989-0643 Fax: 314-989-0712 | |
Joanna Lucia Bissell, LCSW, LCSW-C, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 140 Prospect Ave Ste U, Kirkwood, MO 63122 Phone: 314-690-5873 Fax: 314-677-3326 | |
Rachael Arnold, LCSW, PMH-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12166 Old Big Bend Rd Ste 315, Kirkwood, MO 63122 Phone: 314-274-1102 Fax: 314-279-8201 | |
Britney Beussink, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122 Phone: 314-570-0093 | |
Lisa Nicole Eilerts, LCSW, RPT, CATP, JD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 134 W Madison Ave, Kirkwood, MO 63122 Phone: 314-403-0079 |